RhumbLine Advisers’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.06M Buy
162,599
+29,899
+23% +$194K ﹤0.01% 2213
2025
Q1
$1.07M Buy
132,700
+7,860
+6% +$63.5K ﹤0.01% 2138
2024
Q4
$1.54M Buy
124,840
+17,316
+16% +$214K ﹤0.01% 2021
2024
Q3
$882K Sell
107,524
-18,310
-15% -$150K ﹤0.01% 2331
2024
Q2
$628K Buy
125,834
+4,092
+3% +$20.4K ﹤0.01% 2510
2024
Q1
$751K Buy
121,742
+7,147
+6% +$44.1K ﹤0.01% 2421
2023
Q4
$579K Buy
114,595
+3,084
+3% +$15.6K ﹤0.01% 2578
2023
Q3
$641K Buy
111,511
+6,026
+6% +$34.6K ﹤0.01% 2457
2023
Q2
$384K Buy
+105,485
New +$384K ﹤0.01% 2859
2022
Q2
Sell
-40,249
Closed -$80K 3250
2022
Q1
$80K Buy
40,249
+2,566
+7% +$5.1K ﹤0.01% 2929
2021
Q4
$118K Buy
37,683
+633
+2% +$1.98K ﹤0.01% 2919
2021
Q3
$182K Buy
37,050
+2,670
+8% +$13.1K ﹤0.01% 2924
2021
Q2
$229K Buy
34,380
+3,865
+13% +$25.7K ﹤0.01% 2888
2021
Q1
$171K Sell
30,515
-365
-1% -$2.05K ﹤0.01% 2865
2020
Q4
$243K Buy
30,880
+5,155
+20% +$40.6K ﹤0.01% 2762
2020
Q3
$218K Sell
25,725
-2,715
-10% -$23K ﹤0.01% 2648
2020
Q2
$296K Sell
28,440
-1,912
-6% -$19.9K ﹤0.01% 2583
2020
Q1
$284K Buy
30,352
+805
+3% +$7.53K ﹤0.01% 2430
2019
Q4
$237K Buy
29,547
+387
+1% +$3.1K ﹤0.01% 2692
2019
Q3
$599K Buy
29,160
+618
+2% +$12.7K ﹤0.01% 2253
2019
Q2
$745K Buy
28,542
+2,934
+11% +$76.6K ﹤0.01% 2195
2019
Q1
$995K Buy
25,608
+2,838
+12% +$110K ﹤0.01% 2036
2018
Q4
$957K Buy
22,770
+7,733
+51% +$325K ﹤0.01% 2036
2018
Q3
$752K Sell
15,037
-1,079
-7% -$54K ﹤0.01% 2120
2018
Q2
$616K Buy
16,116
+5,375
+50% +$205K ﹤0.01% 2219
2018
Q1
$431K Buy
10,741
+280
+3% +$11.2K ﹤0.01% 2273
2017
Q4
$367K Sell
10,461
-2,216
-17% -$77.7K ﹤0.01% 2364
2017
Q3
$276K Buy
12,677
+175
+1% +$3.81K ﹤0.01% 2589
2017
Q2
$233K Buy
12,502
+4,800
+62% +$89.5K ﹤0.01% 2687
2017
Q1
$212K Buy
+7,702
New +$212K ﹤0.01% 2634
2016
Q4
Sell
-7,862
Closed -$255K 2860
2016
Q3
$255K Buy
+7,862
New +$255K ﹤0.01% 2563